SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001703057-23-000024
Filing Date
2023-08-09
Accepted
2023-08-09 12:22:00
Documents
1
Period of Report
2023-08-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1691598110.html 4  
1 FORM 4 wk-form4_1691598110.xml 4 4874
  Complete submission text file 0001703057-23-000024.txt   6245
Mailing Address C/O ASPREVA PHARMACEUTICALS CORPORATION 1203-4464 MARKHAM STREET VICTORIA A1 V8Z 7X8
Business Address
Hayden Michael R (Reporting) CIK: 0001352908 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39781 | Film No.: 231154231

Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Issuer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences